Home >> Law >> Food & Beverage >>

Gene Signal International SA - Product Pipeline Review - 2015

Published: May-2015 | Format: PDF | Global Markets Direct | Number of pages: 29 | Code: MRS - 19820

Gene Signal International SA - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Gene Signal International SA - Product Pipeline Review - 2015’, provides an overview of the Gene Signal International SA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Gene Signal International SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Gene Signal International SA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Gene Signal International SA’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Gene Signal International SA’s pipeline products

Reasons to buy

- Evaluate Gene Signal International SA’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Gene Signal International SA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Gene Signal International SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Gene Signal International SA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Gene Signal International SA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Gene Signal International SA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Gene Signal International SA Snapshot 5
Gene Signal International SA Overview 5
Key Information 5
Key Facts 5
Gene Signal International SA - Research and Development Overview 6
Key Therapeutic Areas 6
Gene Signal International SA - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Gene Signal International SA - Pipeline Products Glance 10
Gene Signal International SA - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Gene Signal International SA - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Gene Signal International SA - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Gene Signal International SA - Drug Profiles 15
aganirsen 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
GS-156 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
GS-168 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
GS-497c 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
GS-156 mAB 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Gene Signal International SA - Pipeline Analysis 21
Gene Signal International SA - Pipeline Products by Target 21
Gene Signal International SA - Pipeline Products by Route of Administration 22
Gene Signal International SA - Pipeline Products by Molecule Type 23
Gene Signal International SA - Pipeline Products by Mechanism of Action 24
Gene Signal International SA - Recent Pipeline Updates 25
Gene Signal International SA - Dormant Projects 26
Gene Signal International SA - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 28
Disclaimer 29

List of Tables
Gene Signal International SA, Key Information 5
Gene Signal International SA, Key Facts 5
Gene Signal International SA - Pipeline by Indication, 2015 7
Gene Signal International SA - Pipeline by Stage of Development, 2015 8
Gene Signal International SA - Monotherapy Products in Pipeline, 2015 9
Gene Signal International SA - Phase III, 2015 10
Gene Signal International SA - Phase II, 2015 11
Gene Signal International SA - Phase I, 2015 12
Gene Signal International SA - Preclinical, 2015 13
Gene Signal International SA - Discovery, 2015 14
Gene Signal International SA - Pipeline by Target, 2015 21
Gene Signal International SA - Pipeline by Route of Administration, 2015 22
Gene Signal International SA - Pipeline by Molecule Type, 2015 23
Gene Signal International SA - Pipeline Products by Mechanism of Action, 2015 24
Gene Signal International SA - Recent Pipeline Updates, 2015 25
Gene Signal International SA - Dormant Developmental Projects,2015 26
Gene Signal International SA, Subsidiaries 27

List of Figures
Gene Signal International SA - Pipeline by Top 10 Indication, 2015 7
Gene Signal International SA - Pipeline by Stage of Development, 2015 8
Gene Signal International SA - Monotherapy Products in Pipeline, 2015 9
Gene Signal International SA - Pipeline by Top 10 Target, 2015 21
Gene Signal International SA - Pipeline by Top 10 Route of Administration, 2015 22
Gene Signal International SA - Pipeline by Top 10 Molecule Type, 2015 23
Gene Signal International SA - Pipeline Products by Top 10 Mechanism of Action, 2015 24

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing